Surya Singh to Erlotinib Hydrochloride
This is a "connection" page, showing publications Surya Singh has written about Erlotinib Hydrochloride.
Connection Strength
0.054
-
Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells. Prostate. 2023 May; 83(6):534-546.
Score: 0.054
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.